A detailed history of Sih Partners, Lllp transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Sih Partners, Lllp holds 14,897 shares of ADMA stock, worth $297,046. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,897
Holding current value
$297,046
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$15.44 - $20.61 $230,009 - $307,027
14,897 New
14,897 $296 Million

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.92B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Sih Partners, Lllp Portfolio

Follow Sih Partners, Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sih Partners, Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Sih Partners, Lllp with notifications on news.